[Clinical trials with a new beta-sympatholytic agent].
作者信息
Beyreder J, Brandstetter G
出版信息
Wien Med Wochenschr. 1973 Feb 10;123(6):76-81.
PMID:4405628
Abstract
摘要
相似文献
1
[Clinical trials with a new beta-sympatholytic agent].[一种新型β-肾上腺素能阻滞剂的临床试验]
Wien Med Wochenschr. 1973 Feb 10;123(6):76-81.
2
[Anti-arrhythmic effect of a new adrenergic beta receptor blocking substance].
Arq Bras Cardiol. 1972 Dec;25(6):471-5.
3
[Cardiovascular-active agents. Problems of dosage and adverse effects].[心血管活性药物。剂量问题与不良反应]
Int Z Klin Pharmakol Ther Toxikol. 1971 Dec;5(3):315-9.
4
[Use of LB-46 in angina pectoris and cardiac arrhythmias].
Arq Bras Cardiol. 1972 Feb;25(1):51-60.
5
[Clinical study of a new beta-blocking agent: LB 46].
Lille Med. 1971 Oct;16:Suppl 4:1203-8.
6
[Up-dating the treatment with beta-blockaders in cardiology].[心脏病学中β受体阻滞剂治疗的更新]
Rev Clin Esp. 1977 Oct 15;147(1):103-12.
7
Esmolol--a short-acting i.v. beta-blocker.
Med Lett Drugs Ther. 1987 Jun 19;29(742):57-8.
8
9
10
Ivabradine versus bisoprolol.伊伐布雷定与比索洛尔对比
Minerva Cardioangiol. 2010 Apr;58(2):281-2.
Zotero 插件